scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/J.IMBIO.2011.07.005 |
P698 | PubMed publication ID | 21821307 |
P2093 | author name string | Ralph W Moss | |
Jitendra N Mehrishi | |||
Tibor Bakacs | |||
P433 | issue | 6 | |
P921 | main subject | ipilimumab | Q2459042 |
P304 | page(s) | 583-589 | |
P577 | publication date | 2011-07-07 | |
P1433 | published in | Immunobiology | Q15754985 |
P1476 | title | Ipilimumab (Yervoy) and the TGN1412 catastrophe | |
P478 | volume | 217 |
Q37064737 | A pharmacologic perspective on newly emerging T-cell manipulation technologies |
Q39316966 | An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas |
Q39037052 | Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication |
Q37743471 | Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer |
Q26740520 | CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas |
Q37675090 | Chemical Tools To Monitor and Manipulate Adaptive Immune Responses |
Q38523302 | Evolving Concepts: Immunity in Oncology from Targets to Treatments |
Q35090797 | Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists |
Q64072367 | MiStImm: an agent-based simulation tool to study the self-nonself discrimination of the adaptive immune response |
Q88678430 | Obesity as an immune-modifying factor in cancer immunotherapy |
Q34618599 | Serum antibodies against CD28-- a new potential marker of dismal prognosis in melanoma patients |
Q90172521 | Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies |
Q36687229 | Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors-an autopsy study |
Q92144029 | The pharmacology and therapeutic applications of monoclonal antibodies |
Q27014693 | Update on the challenges and recent advances in cancer immunotherapy |
Search more.